Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.

Torosyan Y, Dobi A, Naga S, Mezhevaya K, Glasman M, Norris C, Jiang G, Mueller G, Pollard H, Srivastava M.

Cancer Res. 2006 Oct 1;66(19):9609-16.

2.

Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells.

Torosyan Y, Dobi A, Glasman M, Mezhevaya K, Naga S, Huang W, Paweletz C, Leighton X, Pollard HB, Srivastava M.

Oncogene. 2010 Apr 29;29(17):2457-66. doi: 10.1038/onc.2010.2. Epub 2010 Mar 1.

PMID:
20190808
3.

Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.

Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ.

Cancer Res. 2003 May 1;63(9):2256-67.

4.

Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.

Torosyan Y, Simakova O, Naga S, Mezhevaya K, Leighton X, Diaz J, Huang W, Pollard H, Srivastava M.

Int J Cancer. 2009 Dec 1;125(11):2528-39. doi: 10.1002/ijc.24592.

5.

Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.

Kelavkar UP, Cohen C, Kamitani H, Eling TE, Badr KF.

Carcinogenesis. 2000 Oct;21(10):1777-87.

PMID:
11023533
6.

Expression of prostate specific antigen (PSA) is negatively regulated by p53.

Gurova KV, Roklin OW, Krivokrysenko VI, Chumakov PM, Cohen MB, Feinstein E, Gudkov AV.

Oncogene. 2002 Jan 3;21(1):153-7.

7.

Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.

Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.

Int J Oncol. 2004 Apr;24(4):821-7.

PMID:
15010818
8.
9.

15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.

Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN.

Cancer Res. 2001 Jan 15;61(2):497-503.

10.

Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.

Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D.

Oncogene. 2003 Jul 31;22(31):4831-40.

PMID:
12894224
11.

15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.

Subbarayan V, Krieg P, Hsi LC, Kim J, Yang P, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG.

Oncogene. 2006 Sep 28;25(44):6015-25. Epub 2006 May 8.

PMID:
16682954
12.
13.

p53 regulates the expression of the tumor suppressor gene maspin.

Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S.

J Biol Chem. 2000 Mar 3;275(9):6051-4.

14.

Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.

Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA Jr, Shappell SB.

Hum Pathol. 2000 Sep;31(9):1146-54.

PMID:
11014584
15.

Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.

Srivastava M, Leighton X, Starr J, Eidelman O, Pollard HB.

Biomed Res Int. 2014;2014:193635. doi: 10.1155/2014/193635. Epub 2014 Apr 22.

16.

Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells.

Tang S, Bhatia B, Zhou J, Maldonado CJ, Chandra D, Kim E, Fischer SM, Butler AP, Friedman SL, Tang DG.

Oncogene. 2004 Sep 9;23(41):6942-53.

PMID:
15247906
17.

Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.

Benoit V, Hellin AC, Huygen S, Gielen J, Bours V, Merville MP.

Oncogene. 2000 Sep 28;19(41):4787-94.

18.

Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.

Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H.

Anticancer Res. 2000 Jan-Feb;20(1A):417-22.

PMID:
10769689
19.

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J.

BMC Cancer. 2009 Jun 7;9:173. doi: 10.1186/1471-2407-9-173.

20.

Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.

Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM.

Cancer Res. 2001 Jun 15;61(12):4879-84.

Supplemental Content

Support Center